Dengue Serotype Cross-Reactive, Anti-E Protein Antibodies Confound Specific Immune Memory for 1 Year after Infection
Dengue virus has four serotypes and is endemic globally in tropical countries. Neither a specific treatment nor an approved vaccine is available, and correlates of protection are not established. The standard neutralization assay cannot differentiate between serotype-specific and serotype cross-reac...
Saved in:
Main Authors: | Toh, Ying Xiu, Gan, Victor, Balakrishnan, Thavamalar, Zuest, Roland, Poidinger, Michael, Wilson, Solomonraj, Appanna, Ramapraba, Thein, Tun Linn, Ong, Adrian Kheng-Yeow, Ng, Lee Ching, Leo, Yee Sin, Fink, Katja |
---|---|
Other Authors: | Lee Kong Chian School of Medicine (LKCMedicine) |
Format: | Article |
Language: | English |
Published: |
2015
|
Subjects: | |
Online Access: | https://hdl.handle.net/10356/80938 http://hdl.handle.net/10220/38982 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Nanyang Technological University |
Language: | English |
Similar Items
-
CHARACTERIZATION OF DENGUE NEUTRALIZING ANTIBODIES USING RECOMBINANT ANTIBODIES TECHNOLOGY
by: XU MEIHUI
Published: (2015) -
Dengue serotype cross-reactive, anti-E protein antibodies confound specific immune memory for 1 year after infection
by: Toh, Y.X, et al.
Published: (2020) -
Clinical development and regulatory points for consideration for second-generation live attenuated dengue vaccines
by: Vannice, Kirsten S., et al.
Published: (2018) -
Low antibody titers five years after vaccination with the CYD-TDV dengue vaccine in both pre-immune and naïve vaccinees
by: Velumani, Sumathy, et al.
Published: (2016) -
Moving forward with Takeda's live chimeric tetravalent dengue vaccine
by: Wilder-Smith, Annelies
Published: (2017)